Description: China Dongcheng Pharmaceutical Groupwas established in 1998 and listed on the Shenzhen Stock Exchange (stock code: 002675) in May 2012. After over 20 years of development, Yantai Dongcheng Pharmaceutical Group Co., Ltd. has become a large pharmaceutical group covering four fields: biochemical APIs, chemical medicines, proprietary Chinese medicines and nuclide drugs, which integrates the research and development, production and sales of medicines.Heparin Sodium,Enoxaparin Sodium ,Nadroparin Calcium ,Daltep
chondroitin (38) heparin sodium (5) china chondroitin glucosamine capsule (1) gmp heparin (1) dmf heparin supplier (1) gmp chondroitin supplier (1) usp grade chondroitin supplier (1) china heparin sodium (1) china enoxaparin sodium (1) china nadroparin calcium (1)
Dongcheng (stock code: 002675) the first Chinese supplier of heparin sodium which passes the MFDS GMP audit by the Korea Food & Drug Administration and the PMDA GMP on-site inspection by Japan, and holds the GMP certificates issued by BGV in Hamburg, Germany and CFDA in China, as well as the CEP certificate issued by EDQM in Europe; European Pharmacopoeia and United States Pharmacopeia concerning the heparin sodium API.
Dongcheng Pharmaceutical was founded in 1998 and went public in 2012
Biochemical raw materials, chemical drugs, Chinese patent medicine, nuclear drugs four fields